Identification of contractile P2Y1, P2Y6, and P2Y12 receptors in rat intrapulmonary artery using selective ligands

Journal of Pharmacology and Experimental Therapeutics

Volumn 343, Issue 3, 2012, Pages 755-762

  Mitchell, Callum ^a   Syed, Nawazish I Husain ^a,b   Tengah, Asrin ^a,c   Gurney, Alison M ^a,d   Kennedy, Charles ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF THE PUNJAB   (Pakistan)

^c UNIVERSITI BRUNEI DARUSSALAM   (Brunei Darussalam)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; 3 (2 OXO 2 PHENYLETHYL)URIDINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CANGRELOR; CYSTEINYLLEUKOTRIENE 1 RECEPTOR; LEUKOTRIENE RECEPTOR; MESSENGER RNA; N METHANOCARBA 2 METHYLTHIOADENOSINE 5' O DIPHOSPHATE; N,N' 1,4 BUTANEDIYLBIS N' (3 ISOTHIOCYANATOPHENYL)THIOUREA; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y RECEPTOR AGONIST; PURINERGIC P2Y RECEPTOR ANTAGONIST; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y14 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; UNCLASSIFIED DRUG; VERLUKAST; LIGAND; P2Y12 PROTEIN, RAT; PURINERGIC P2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY TONE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PULMONARY ARTERY; RAT; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; METABOLISM; SPRAGUE DAWLEY RAT; VASOCONSTRICTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOMETRIC CONTRACTION; LIGANDS; MALE; PULMONARY ARTERY; PURINERGIC P2Y RECEPTOR AGONISTS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; RECEPTORS, PURINERGIC P2Y1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASOCONSTRICTION;

EID: 84869237223     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.198051     Document Type: Article

References (58)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, et al. (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281-341. (Pubitemid 44394905)
2. Adnot S, Raffestin B, Eddahibi S, Braquet P, and Chabrier PE (1991) Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 87:155-162.
3. Baek EB, Yoo HY, Park SJ, Kim HS, Kim SD, Earm YE, and Kim SJ (2008) Luminal ATP-induced contraction of rabbit pulmonary arteries and role of purinoceptors in the regulation of pulmonary arterial pressure. Pflugers Arch 457:281-291.
4. Barnes PJ and Liu SF (1995) Regulation of pulmonary vascular tone. Pharmacol Rev 47:87-131.
5. Bodor ET, Waldo GL, Hooks SB, Corbitt J, Boyer JL, and Harden TK (2003) Purification and functional reconstitution of the human P2Y12 receptor. Mol Pharmacol 64:1210-1216. (Pubitemid 37310754)
6. 6-methyl 2′-deoxyadenosine 3′,5′-bisphosphate. Br J Pharmacol 124:1-3.
7. Burnstock G and Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16:433-440. (Pubitemid 16250911)
8. Burnstock G and Kennedy C (1986) A dual function for adenosine 5′-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ Res 58:319-330. (Pubitemid 16120755)
9. Burnstock G and Kennedy C (2011) P2X receptors in health and disease. Adv Pharmacol 61:333-372.
10. Camaioni E, Boyer JL, Mohanram A, Harden TK, and Jacobson KA (1998) Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors. J Med Chem 41:183-190. (Pubitemid 28114360)
11. 14receptor. Mol Pharmacol 76:1341-1348.
12. Chambers JK, Macdonald LE, Sarau HM, Ames RS, Freeman K, Foley JJ, Zhu Y, McLaughlin MM, Murdock P, McMillan L, et al. (2000) A G protein-coupled receptor for UDP-glucose. J Biol Chem 275:10767-10771. (Pubitemid 30212705)
13. 13 receptors by conformational constraint of an ADP analog. J Pharmacol Exp Ther 311:1038-1043.
14. Chootip K, Gurney AM, and Kennedy C (2005) Multiple P2Y receptors couple to calcium-dependent, chloride channels in smooth muscle cells of the rat pulmonary artery. Respir Res 6:124.
15. Chootip K, Ness KF, Wang Y, Gurney AM, and Kennedy C (2002) Regional variation in P2 receptor expression in the rat pulmonary arterial circulation. Br J Pharmacol 137:637-646. (Pubitemid 35333089)
16. Cusack NJ and Hourani SM (1982) Adenosine 5′-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors. Br J Pharmacol 76:221-227. (Pubitemid 12153496)
17. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, and Wallwork J (1991) Impairment of endothelium- dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med 324:1539-1547.
18. 6 receptors. J Med Chem 49:7076-7087.
19. Erlinge D and Burnstock G (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4:1-20.
20. 2- purinoceptors in the smooth muscle of the rat tail artery; a comparison between contractile and electrophysiological responses. Br J Pharmacol 113:853-860.
21. Freeman K, Tsui P, Moore D, Emson PC, Vawter L, Naheed S, Lane P, Bawagan H, Herrity N, Murphy K, et al. (2001) Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs. Genomics 78:124-128. (Pubitemid 34001415)
22. 14 receptors is a mediator of mast cell degranulation. Biochem Pharmacol 79:873-879.
23. 2+ signalling by P2Y receptors in cultured rat aortic smooth muscle cells. Br J Pharmacol 160:1953-1962.
24. 4A stimulates endothelium-independent contraction of isolated rat pulmonary artery. Am J Physiol Lung Cell Mol Physiol 294:L733-L738.
25. Hartley SA, Kato K, Salter KJ, and Kozlowski RZ (1998) Functional evidence for a novel suramin-insensitive pyrimidine receptor in rat small pulmonary arteries. Circ Res 83:940-946. (Pubitemid 28503083)
26. Hasséssian H and Burnstock G (1995) Interacting roles of nitric oxide and ATP in the pulmonary circulation of the rat. Br J Pharmacol 114:846-850.
27. 12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature. Int J Cardiol 142:187-192.
28. Ingall AH, Dixon J, Bailey A, Coombs ME, Cox D, McInally JI, Hunt SF, Kindon ND, Teobald BJ, Willis PA, et al. (1999) Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J Med Chem 42:213-220. (Pubitemid 29069856)
29. Jernigan NL, Broughton BR, Walker BR, and Resta TC (2006) Impaired NO-dependent inhibition of store- and receptor-operated calcium entry in pulmonary vascular smooth muscle after chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 290:L517-L525. (Pubitemid 43725096)
30. Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Frenette R, Gauthier JY, Leger S, and Masson P (1989) Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol 67:17-28. (Pubitemid 19068107)
31. Kennedy C and Leff P (1995) How should P2X purinoceptors be classified pharmacologically? Trends Pharmacol Sci 16:168-174.
32. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Ségué la P, Voigt M, and Humphrey PP (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53:107-118. (Pubitemid 32173110)
33. 2+ channels in PC12 cells by antithrombotic drugs. Br J Pharmacol 138:343-350.
34. Liu SF, McCormack DG, Evans TW, and Barnes PJ (1989a) Characterization and distribution of P2-purinoceptor subtypes in rat pulmonary vessels. J Pharmacol Exp Ther 251:1204-1210. (Pubitemid 20024946)
35. 2-purinoceptor subtypes in human small pulmonary arteries. Br J Pharmacol 98:1014-1020.
36. Lommatzsch M, Cicko S, Müller T, Lucattelli M, Bratke K, Stoll P, Grimm M, Dürk T, Zissel G, Ferrari D, et al. (2010) Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181:928-934.
37. 1receptor up-regulates nucleoside-triphosphate diphosphohydrolase-1 in human retinal pigment epithelial cells. J Pharmacol Exp Ther 323:157-164.
38. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, et al. (1999) Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399:789-793. (Pubitemid 29293175)
39. Macfarlane DE and Mills DC (1975) The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood 46:309-320.
40. Mam V, Tanbe AF, Vitali SH, Arons E, Christou HA, and Khalil RA (2010) Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats. J Pharmacol Exp Ther 332:455-462.
41. Mamedova LK, Joshi BV, Gao ZG, von Kügelgen I, and Jacobson KA (2004) Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. Biochem Pharmacol 67:1763-1770. (Pubitemid 38479854)
42. McCormack DG, Barnes PJ, and Evans TW (1989) Purinoceptors in the pulmonary circulation of the rat and their role in hypoxic vasoconstriction. Br J Pharmacol 98:367-372. (Pubitemid 19245741)
43. Mellor EA, Austen KF, and Boyce JA (2002) Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J Exp Med 195:583-592. (Pubitemid 34461503)
44. Mellor EA, Maekawa A, Austen KF, and Boyce JA (2001) Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci U S A 98:7964-7969. (Pubitemid 32642670)
45. v1.2 ion channels play major roles in P2Y receptor-mediated pulmonary vasoconstriction. Br J Pharmacol 166:1503-1512.
46. Palmer RK, Boyer JL, Schachter JB, Nicholas RA, and Harden TK (1998) Agonist action of adenosine triphosphates at the human P2Y1 receptor. Mol Pharmacol 54:1118-1123. (Pubitemid 29002057)
47. Ravi RG, Kim HS, Servos J, Zimmermann H, Lee K, Maddileti S, Boyer JL, Harden TK, and Jacobson KA (2002) Adenine nucleotide analogues locked in a northern methanocarba conformation: enhanced stability and potency as P2Y1 receptor agonists. J Med Chem 45:2090-2100. (Pubitemid 34477721)
48. Robson SC, Sévigny J, and Zimmermann H (2006) The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2:409-430.
49. Rubino A and Burnstock G (1996) Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat. Br J Pharmacol 118:1415-1420. (Pubitemid 26248793)
50. Rubino A, Ziabary L, and Burnstock G (1999) Regulation of vascular tone by UTP and UDP in isolated rat intrapulmonary arteries. Eur J Pharmacol 370:139-143. (Pubitemid 29185100)
51. Sprague RS, Ellsworth ML, Stephenson AH, and Lonigro AJ (1996) ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol Heart Circ Physiol 271:H2717-H2722.
52. Sprague RS, Olearczyk JJ, Spence DM, Stephenson AH, Sprung RW, and Lonigro AJ (2003) Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am J Physiol Heart Circ Physiol 285:H693-H700. (Pubitemid 36885902)
53. Syed NH and Kennedy C (2012) Pharmacology of P2X receptors. WIREs Membr Transp Signal 1:16-30.
54. Syed NI, Tengah A, Paul A, and Kennedy C (2010) Characterisation of P2X receptors expressed in rat pulmonary arteries. Eur J Pharmacol 649:342-348.
55. Takasaki J, Kamohara M, Saito T, Matsumoto M, Matsumoto S, Ohishi T, Soga T, Matsushime H, and Furuichi K (2001) Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y1receptor. Mol Pharmacol 60:432-439. (Pubitemid 32781549)
56. 6-like receptor in arteries. Mol Pharmacol 62:1438-1445.
57. 1 receptors to disruption of lipid rafts. Biochem Biophys Res Commun 343:415-419.
58. 12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24:1810-1815.